Myocarditis or Pericarditis Following mRNA COVID-19 Vaccination
JAMA Netw Open
.
2022 Jun 1;5(6):e2218512.
doi: 10.1001/jamanetworkopen.2022.18512.
Authors
Eric S Weintraub
1
,
Matthew E Oster
1
2
,
Nicola P Klein
3
Affiliations
1
Immunization Safety Office, US Centers for Disease Control and Prevention, Atlanta, Georgia.
2
Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
3
Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland.
PMID:
35749119
PMCID:
PMC9340663
DOI:
10.1001/jamanetworkopen.2022.18512
No abstract available
Publication types
Comment
MeSH terms
COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Humans
Myocarditis* / etiology
Pericarditis* / etiology
RNA, Messenger
Vaccination / adverse effects
Substances
COVID-19 Vaccines
RNA, Messenger
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States